• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.
    All News #Library
    Biotech

    Ligand Pharma to Acquire Biotech Royalty Rights Buyer XOMA

    REUTERS

    XOMA Royalty To Release 2025 Financial Results On March 18, 2026

    GLOBENEWSWIRE

    XOMA Royalty To Present At Investor Conferences In March

    GLOBENEWSWIRE

    XOMA Royalty Enters Into Agreement To Acquire Generation Bio

    GLOBENEWSWIRE

    XOMA Royalty Completes Acquisition Of Mural Oncology

    GLOBENEWSWIRE

    XOMA Royalty Announces Tender Offer Closure for HilleVax

    GLOBENEWSWIRE

    Mural Agrees to Xoma Buyout After Being Cornered

    FIERCE BIOTECH

    XOMA Reports Q2 and YTD 2025 Financial Results and Achievements

    GLOBENEWSWIRE

    XOMA Closes Tender Offer for Turnstone Biologics

    GLOBENEWSWIRE

    Xoma shops for struggling biotechs, buying HilleVax and Lava

    FIERCE BIOTECH

    XOMA Royalty to Acquire LAVA Therapeutics for Up to $1.24 Cash

    GLOBENEWSWIRE

    HilleVax Enter into a Definitive Agreement to be Acquired by XOMA

    GLOBENEWSWIRE

    Turnstone, once allied with AbbVie, accepts $8M Xoma buyout

    FIERCE BIOTECH

    XOMA buys Mezagitamab rights from BioInvent for up to $30M

    GLOBENEWSWIRE

    XOMA Royalty Reports Q1 2025 Financial Results & Business Achieve

    GLOBENEWSWIRE

    XOMA Royalty to Present at H.C. Wainwright Conference

    GLOBENEWSWIRE

    XOMA Royalty to Present at Jones Healthcare Conference

    GLOBENEWSWIRE

    XOMA Royalty Reports Q4 and Full Year 2024 Financial Results

    GLOBENEWSWIRE

    Twist Bioscience Enters Royalty Purchase Agreement For $15M

    BUSINESSWIRE

    XOMA Royalty to Present at Upcoming Investor Conferences

    GLOBENEWSWIRE

    XOMA Earns $9M As FDA Approves Day One`s Tovorafenib For pLGG

    GLOBENEWSWIRE

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.